Bai Zhongquan

Chairman and Party Secretary · Sinopharm

Pharmaceuticals and Healthcare

Bai Zhongquan is chairman and party secretary of China National Pharmaceutical Group, known as Sinopharm. His earlier career encompassed defense-industry technology and planning, steel research and electrical-equipment manufacturing.

Last reviewed: Nov 6, 2026

Bai Zhongquan

Chairman and Party Secretary
Sinopharm

Last Reviewed: November 6, 2026

Executive Summary

Bai Zhongquan is chairman and party secretary of China National Pharmaceutical Group, known as Sinopharm. His earlier career encompassed defense-industry technology and planning, steel research and electrical-equipment manufacturing.

Career Highlights

  • Served in technology, quality, planning and executive roles in China’s defense-equipment industry.
  • Led China Iron & Steel Research Institute Group before chairmanships in electrical equipment.
  • Appointed Sinopharm chairman and party secretary in 2024.

Professional Journey

Bai’s early career included technology and quality-management positions in China’s former national ordnance-industry corporation. He served as deputy head of the science-and-technology committee secretariat, led a technical office within quality supervision, and headed civilian-products work in the science-and-technology organization.

At China South Industries Group, he progressed through deputy leadership of science and quality, director of the general office, director of development planning, assistant general manager and deputy general manager. He also held concurrent director, party-secretary and deputy-general-manager positions at Baoding Tianwei Group.

He became a director and general manager of China Iron & Steel Research Institute Group in March 2012. He later moved into electrical equipment, becoming chairman of China XD Group on September 29, 2018. His subsequent career included chairing China Electrical Equipment Group.

In an October 2023 interview as China Electrical Equipment chairman, he described integrating its constituent businesses, consolidating procurement and accelerating digital manufacturing. He attributed improved operating efficiency to technology-led cost reduction, shared resources and smarter production, and described creating research, supply-chain, investment and other shared platforms.

Sinopharm announced his appointment as chairman and party secretary in June 2024, succeeding Liu Jingzhen. He now leads the parent pharmaceutical and healthcare group.

Education

Bai holds a master’s degree in engineering. His AT&M biography also lists Tsinghua University’s EMBA program.